Profil
Dr. Richard B.
Gayle is on the Board of Directors at Etubics Corp.
Dr. Gayle was previously employed as Senior Scientist by Immunex Corp.
He also served on the board at Sustainable Path Foundation.
He received his undergraduate degree from Rice University and a doctorate degree from the California Institute of Technology.
Ehemalige bekannte Positionen von Richard B. Gayle
| Unternehmen | Position | Ende |
|---|---|---|
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 |
| Sustainable Path Foundation | Gründer | - |
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Richard B. Gayle
| Rice University | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Etubics Corp.
Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Health Technology |
| Sustainable Path Foundation |
